|
|
||||||||
Ann Thorac Surg 1996;62:578-580
© 1996 The Society of Thoracic Surgeons
Divisions of Cardiothoracic Surgery and Pediatric Cardiology, College of Physicians and Surgeons of Columbia University, New York, New York
Accepted for publication February 26, 1996.
| Abstract |
|---|
|
|
|---|
-year-old boy with idiopathic cardiomyopathy and rapidly worsening hemodynamic parameters underwent placement of a biventricular assist device as a bridge to transplantation. Direct anastomoses to both the aorta and pulmonary artery with Dacron grafts attached to Carmeda-coated tubing facilitated the support period. Inflow was provided by right atrial appendage and left ventricular apex cannulas. A centrifugal pump provided support for 2 days until a suitable donor was identified. The technique is simple, reproducible, and effective for patients with small body surface areas. | Introduction |
|---|
|
|
|---|
Reluctance on the part of surgeons to intervene in these cases has arisen in part from the limited device options available. The only Food and Drug Administration-approved device for long-term bridging to heart transplantation in the United States, the ThermoCardiosystems Heartmate (Woburn, MA), can only be implanted in patients whose body surface area is more than 1.5 m2. Although this has allowed us to successfully salvage patients as young as 13 years old, smaller patients cannot be helped. The ABIOMED BVS5000 (Danvers, MA), a Food and Drug Administration-approved device for postcardiotomy failure, has also been used successfully in young teenagers, but the device must flow at least 3 L/min, making use in patients with a body surface area of less than 1.2 m2 very difficult. At lower flows the thromboembolism incidence becomes prohibitively high without extra anticoagulation. Commercially available devices outside of the United States, including the Berlin heart, have provided satisfactory support in the pediatric population, although these pumps cannot be used by domestic surgeons.
We present another option for mechanical circulatory support, constructed from Food and Drug Administration-approved, widely available materials, that we have used successfully as a bridge to transplantation.
This 5
-year-old boy with a body surface area of 0.69 m2 first presented to his community hospital with complaints of a nonproductive cough associated with shortness of breath. Evaluation at that time revealed pulmonary edema secondary to severe congestive heart failure necessitating dobutamine, dopamine, and furosemide administration. An echocardiogram revealed dilated and hypokinetic left and right ventricles. Myocardial biopsy was significant for a lymphocytic infiltrate that was managed with one course of intravenous immunoglobulins and methylprednisolone. His was weaned off of inotropic support and later discharged home.
He did well for 1 month at which time he again required admission for inotropic support. His hemodynamics worsened requiring more aggressive management and he was transferred to our institution for an orthotopic heart transplantation. At this point he required 13 µg kg-1 h-1 of dobutamine and 3 µg kg-1 h-1 of dopamine.
While he was in the intensive care unit a massive pulmonary hemorrhage developed associated with oxygen desaturation, and he required intubation. The intubation was complicated by a bradycardia arrest with subsequent chest compressions. Bilateral pneumothoraces later developed, which were managed with chest tube placement. He became febrile and his hemodynamic instability worsened requiring further inotropic and pressor support. Ultimately he began to manifest signs of multiple organ system failure secondary to hypoperfusion. Although his inotropic support was maximized, he became persistently acidotic. At this point we decided that he should undergo placement of a biventricular assist device until a suitable donor became available.
A circuit was constructed by pulling a 8-mm collagen-coated Dacron (Hemashield, Meadox Medicals, Inc, Oakland, NJ) over a Carmeda-coated 0.25-inch Biomedicus tubing (Medtronic Blood Systems, Anaheim, CA) and fastening the two using umbilical tape; this connection was reinforced with sterile silicone type glue (catalog 890, Dow Corning, Midland, MI) (Fig 1
). The Dacron grafts were sewn to the ascending aorta and pulmonary artery. Inflow to the left VAD was provided with a 14F Carmeda-coated DLP cannula (Grand Rapids, MI) inserted into the left ventricular apex. The same venous cannula was used in the right atrium for the right VAD. The cannulas were brought through stab wounds in the right and left upper quadrants and the patient was separated from cardiopulmonary bypass. The patient's chest was closed in the normal fashion after protamine was administered and hemostasis obtained.
|
Two days after biventricular assist device placement a suitable donor was identified. At the time of heart transplantation a white thrombus, which may have existed preoperatively, was identified in the pulmonary artery but not elsewhere. The donor heart ischemic time was 4 hours 40 minutes due to a 3-hour 30-minute travel time. Difficulty was encountered weaning the child off of bypass because of right heart failure and he required the aid of nitric oxide, norepinephrine, epinephrine, isoproterenol, milrinone, and nitroglycerin. He improved postoperatively and was extubated on the third day after transplantation.
His recovery was complicated by the evolution of a stroke. Head computed tomography revealed diffuse watershed ischemic changes in the left frontal, occipital, parietal, and right occipital and parietal lobes. In addition, he had a hemorrhagic area in the right occipital lobe. The stroke was thought to be a result of the low flow state that existed just before device implantation. No evidence for an embolic event existed. He was without any other complications and had excellent cardiac function. To date, he has only a mild residual right-sided weakness.
| Comment |
|---|
|
|
|---|
Second, placement of the left VAD inflow into the left ventricular apex allowed for optimal decompression of the left ventricle. This lessens left ventricular distention, which could inhibit left ventricular recovery in the case of postcardiotomy use. This method reduces stasis, which helps prevent thrombus formation and subsequent embolization.
Third, the use of Carmeda-coated circuits has shown much promise in the laboratory [9, 10] although its clinical benefit has not been as clearly demonstrated [11]. This technology has the potential to avoid or reduce the use of anticoagulation, which would substantially lower the incidence of complications associated with VADs. In this particular case there was no thrombus found on the tubing or within the pump head. Although eventually the patient was maintained on heparin with an activated clotting time of 180 seconds, initially postoperatively no anticoagulation was given. At the time of his orthotopic heart transplant a white thrombus was found in the pulmonary artery, which appeared more than 2 days old; therefore, the thrombus most likely did not originate in the circuit.
Fourth, the method for connecting the tubing to the Dacron graft represents an effective and highly versatile technique for accomplishing an otherwise difficult and crucial aspect of the procedure. There did not appear to be any complications related to this technique.
Finally, this case represents one of the few reported cases of a biventricular assist device serving as a bridge to transplantation in a pediatric patient. Although the support period was quite short, this case suggests a possible alternative to a problem that is currently limited by the absence of small assist devices that are effective in children. Although some reports of potential totally implantable pediatric assist devices [12, 13] exist, until that technology is refined other options must be sought. Another clinically available option, extracorporeal membrane oxygenation, requires incorporation and maintenance of an oxygenator and often will result in hematologic complications during prolonged support. We present a feasible support system, especially in light of a severe shortage of pediatric heart donors; however, additional experience is needed to determine the applicability of this technique to a broad spectrum of patients.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Marelli, H. Laks, D. A. Meehan, D. Fazio, and J. Alejos Minimally invasive mechanical cardiac support without extracorporeal membrane oxygenation in children awaiting heart transplantation Ann. Thorac. Surg., December 1, 1999; 68(6): 2320 - 2323. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Dewey, J. M. Chen, T. B. Spanier, and M. C. Oz Alternative technique of right-sided outflow cannula insertion for right ventricular support Ann. Thorac. Surg., November 1, 1998; 66(5): 1829 - 1830. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |